Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Kalifa

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Brain : a Journal of Neurology|December 13, 2002
Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patientsJean-Sébastien Guillamo, Alain Créange, Chantal Kalifa, et al.
Cancer|June 2, 2007
High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapyVita Ridola, Jacques Grill, Francois Doz, et al.
Cancer Genetics and Cytogenetics|September 19, 2002
Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomasJacques Grill, Hervé Avet-Loiseau, Arielle Lellouch-Tubiana, et al.
Cancer Chemotherapy and Pharmacology|May 9, 2003
In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenograftsGilles Vassal, Jean-Louis Merlin, Marie-José Terrier-Lacombe, et al.
European Journal of Cancer (Oxford, England : 1990)|February 3, 2007
SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patientsMarie-Cécile Le Deley, Jean-Marc Guinebretière, Jean-Claude Gentet, et al.
International Journal of Cancer|February 13, 2007
KIT gene in pediatric osteosarcomas: could it be a new therapeutic target?Natacha Entz-Werle, Marie-Pierre Gaub, Thomas Lavaux, et al.
Journal of Pediatric Hematology/Oncology|August 30, 2014
Patients in pediatric phase I and early phase II clinical oncology trials at Gustave Roussy: a 13-year center experienceFrancisco Bautista, Angela Di Giannatale, Nathalie Dias-Gastellier, et al.
International Journal of Cancer|May 19, 2005
Frequent genomic abnormalities at TWIST in human pediatric osteosarcomasNatacha Entz-Werlé, Corinne Stoetzel, Perrine Berard-Marec, et al.
Hormone Research in Paediatrics|April 17, 2010
Low bone mineral density and high incidences of fractures and vitamin D deficiency in 52 pediatric cancer survivorsKalliopi Bilariki, Elli Anagnostou, Virginie Masse, et al.
Neoplasia (New York, N.Y.)|September 6, 2007
Involvement of MET/TWIST/APC combination or the potential role of ossification factors in pediatric high-grade osteosarcoma oncogenesisNatacha Entz-Werle, Thomas Lavaux, Nadia Metzger, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Brain : a Journal of Neurology|December 13, 2002
Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patientsJean-Sébastien Guillamo, Alain Créange, Chantal Kalifa, et al.
Cancer|June 2, 2007
High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapyVita Ridola, Jacques Grill, Francois Doz, et al.
Cancer Genetics and Cytogenetics|September 19, 2002
Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomasJacques Grill, Hervé Avet-Loiseau, Arielle Lellouch-Tubiana, et al.
Cancer Chemotherapy and Pharmacology|May 9, 2003
In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenograftsGilles Vassal, Jean-Louis Merlin, Marie-José Terrier-Lacombe, et al.
European Journal of Cancer (Oxford, England : 1990)|February 3, 2007
SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patientsMarie-Cécile Le Deley, Jean-Marc Guinebretière, Jean-Claude Gentet, et al.
International Journal of Cancer|February 13, 2007
KIT gene in pediatric osteosarcomas: could it be a new therapeutic target?Natacha Entz-Werle, Marie-Pierre Gaub, Thomas Lavaux, et al.
Journal of Pediatric Hematology/Oncology|August 30, 2014
Patients in pediatric phase I and early phase II clinical oncology trials at Gustave Roussy: a 13-year center experienceFrancisco Bautista, Angela Di Giannatale, Nathalie Dias-Gastellier, et al.
International Journal of Cancer|May 19, 2005
Frequent genomic abnormalities at TWIST in human pediatric osteosarcomasNatacha Entz-Werlé, Corinne Stoetzel, Perrine Berard-Marec, et al.
Hormone Research in Paediatrics|April 17, 2010
Low bone mineral density and high incidences of fractures and vitamin D deficiency in 52 pediatric cancer survivorsKalliopi Bilariki, Elli Anagnostou, Virginie Masse, et al.
Neoplasia (New York, N.Y.)|September 6, 2007
Involvement of MET/TWIST/APC combination or the potential role of ossification factors in pediatric high-grade osteosarcoma oncogenesisNatacha Entz-Werle, Thomas Lavaux, Nadia Metzger, et al.
Pageof 4